Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Orchestra BioMed Holdings, Inc. - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS
Ticker
Exchange
SIC #
Website
Latest Ticker
OBIO
Nasdaq
3841
orchestrabiomed.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Orchestra BioMed Holdings, Inc.
Orchestra BioMed to Participate in the Piper Sandler 36th Annual Healthcare Conference
- Nov 26th, 2024 9:05 pm
Orchestra BioMed Holdings Third Quarter 2024 Earnings: Beats Expectations
- Nov 14th, 2024 10:07 am
We Think Orchestra BioMed Holdings (NASDAQ:OBIO) Needs To Drive Business Growth Carefully
- Nov 14th, 2024 10:05 am
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q3 Loss, Tops Revenue Estimates
- Nov 12th, 2024 11:05 pm
Orchestra BioMed Reports Third Quarter 2024 Financial Results and Provides a Business Update
- Nov 12th, 2024 9:12 pm
Orchestra BioMed to Participate in Jefferies London Healthcare Conference
- Nov 7th, 2024 1:00 pm
Travere (TVTX) Surges 11.6%: Is This an Indication of Further Gains?
- Oct 7th, 2024 8:44 am
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q2 Loss, Lags Revenue Estimates
- Aug 12th, 2024 9:35 pm
Orchestra BioMed Reports Second Quarter 2024 Financial Results and Provides a Business Update
- Aug 12th, 2024 8:20 pm
Orchestra BioMed Holdings, Inc. (OBIO) Loses -25.35% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
- Aug 8th, 2024 1:35 pm
Earnings Preview: Fortrea Holdings Inc. (FTRE) Q2 Earnings Expected to Decline
- Aug 5th, 2024 2:00 pm
Orchestra BioMed Holdings, Inc. (OBIO) Expected to Beat Earnings Estimates: Should You Buy?
- Aug 1st, 2024 2:01 pm
Orchestra BioMed Announces Appointment of Cardiovascular Device Industry Expert John Mack to Board of Directors
- Jul 30th, 2024 12:00 pm
Orchestra BioMed Holdings, Inc. (OBIO) Upgraded to Buy: Here's What You Should Know
- Jul 26th, 2024 4:00 pm
Wall Street Analysts Believe Orchestra BioMed Holdings, Inc. (OBIO) Could Rally 102.61%: Here's is How to Trade
- Jul 26th, 2024 1:55 pm
Precision Neuroscience Expands Executive Team as Brain–Computer Interface Industry Rapidly Advances
- Jul 23rd, 2024 1:00 pm
Orchestra BioMed Holdings, Inc. (OBIO) Stock Jumps 7.3%: Will It Continue to Soar?
- Jun 24th, 2024 12:07 pm
Orchestra BioMed Holdings, Inc.'s (NASDAQ:OBIO) largest shareholders are individual investors with 37% ownership, public companies own 16%
- Jun 18th, 2024 11:39 am
Orchestra BioMed Announces Further Details on In-Person R&D Day in New York Featuring Key Opinion Leaders to Discuss AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024
- Jun 4th, 2024 12:00 pm
All You Need to Know About Orchestra BioMed Holdings, Inc. (OBIO) Rating Upgrade to Buy
- Jun 3rd, 2024 4:00 pm
Scroll